Literature DB >> 35440803

Clinical and immunologic responses to extracorporeal photopheresis and low-dose IL-2 in patients with steroid refractory chronic graft-versus host disease.

Amandeep Salhotra1, Min Talley2, Xiwei Wu3, Weimin Tsai4, Sally Mokhtari5, Hanjun Qin3, Monzr M Al-Malki4, Ibrahim Aldoss4, Badri Modi6, Paul Koller4, Erin Kopp4, Eileen Smith4, Anna Pawlowska7, Ryotaro Nakamura4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35440803     DOI: 10.1038/s41409-022-01671-0

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.174


× No keyword cloud information.
  9 in total

1.  Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers.

Authors:  Sawa Ito; Catherine M Bollard; Mattias Carlsten; Jan Joseph Melenhorst; Angélique Biancotto; Ena Wang; Jinguo Chen; Yuri Kotliarov; Foo Cheung; Zhi Xie; Francesco Marincola; Kazushi Tanimoto; Minoo Battiwalla; Matthew J Olnes; Shira Perl; Paula Schum; Thomas E Hughes; Keyvan Keyvanfar; Nancy Hensel; Pawel Muranski; Neal S Young; A John Barrett
Journal:  Mol Ther       Date:  2014-04-01       Impact factor: 11.454

2.  Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease.

Authors:  Roger Belizaire; Haesook T Kim; Samuel J Poryanda; Nikola V Mirkovic; Evelyn Hipolito; William J Savage; Carol G Reynolds; Marie J Fields; Jennifer Whangbo; Tomohiro Kubo; Sarah Nikiforow; Edwin P Alyea; Philippe Armand; Corey S Cutler; Vincent T Ho; Bruce R Blazar; Joseph H Antin; Jerome Ritz; Robert J Soiffer; John Koreth
Journal:  Blood Adv       Date:  2019-04-09

3.  Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

Authors:  Daniel R Couriel; Chitra Hosing; Rima Saliba; Elizabeth J Shpall; Paolo Anderlini; Beverly Rhodes; Veronica Smith; Issa Khouri; Sergio Giralt; Marcos de Lima; Yvonne Hsu; Shubhra Ghosh; Joyce Neumann; Borje Andersson; Muzzafar Qazilbash; Sharon Hymes; Stella Kim; Richard Champlin; Michele Donato
Journal:  Blood       Date:  2005-12-20       Impact factor: 22.113

4.  Interleukin-2 and regulatory T cells in graft-versus-host disease.

Authors:  John Koreth; Ken-ichi Matsuoka; Haesook T Kim; Sean M McDonough; Bhavjot Bindra; Edwin P Alyea; Philippe Armand; Corey Cutler; Vincent T Ho; Nathaniel S Treister; Don C Bienfang; Sashank Prasad; Dmitrios Tzachanis; Robin M Joyce; David E Avigan; Joseph H Antin; Jerome Ritz; Robert J Soiffer
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

5.  Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.

Authors:  Emmanuel Zorn; Haesook T Kim; Stephanie J Lee; Blair H Floyd; Despina Litsa; Sankari Arumugarajah; Roberto Bellucci; Edwin P Alyea; Joseph H Antin; Robert J Soiffer; Jerome Ritz
Journal:  Blood       Date:  2005-06-21       Impact factor: 22.113

6.  Failure-free survival after initial systemic treatment of chronic graft-versus-host disease.

Authors:  Yoshihiro Inamoto; Mary E D Flowers; Brenda M Sandmaier; Sahika Z Aki; Paul A Carpenter; Stephanie J Lee; Barry E Storer; Paul J Martin
Journal:  Blood       Date:  2014-05-29       Impact factor: 22.113

7.  Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease.

Authors:  John Koreth; Haesook T Kim; Kyle T Jones; Paulina B Lange; Carol G Reynolds; Marie J Chammas; Katherine Dusenbury; Jennifer Whangbo; Sarah Nikiforow; Edwin P Alyea; Philippe Armand; Corey S Cutler; Vincent T Ho; Yi-Bin Chen; David Avigan; Bruce R Blazar; Joseph H Antin; Jerome Ritz; Robert J Soiffer
Journal:  Blood       Date:  2016-04-12       Impact factor: 22.113

8.  CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.

Authors:  A M Thornton; E M Shevach
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

9.  An essential role for the IL-2 receptor in Treg cell function.

Authors:  Takatoshi Chinen; Arun K Kannan; Andrew G Levine; Xiying Fan; Ulf Klein; Ye Zheng; Georg Gasteiger; Yongqiang Feng; Jason D Fontenot; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2016-09-05       Impact factor: 25.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.